Table of Contents
1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 7
2
Introduction 8
2.1 What Is This Report About? 8
3 Definitions of the
Markets/Categories Covered 9
3.1 Wound Care Management 9
3.1.1
Advanced Wound Management 9
3.1.2 Ostomy 9
4 Company Snapshot 10
4.1 Key Information 10
4.2 Company Overview 10
4.3 Financial
Performance 10
4.4 Industry Outlook -- Hospital Supplies 10
5 Business
Description 11
5.1 Business Overview 11
5.2 Major Products and
Services 11
5.2.1 Overview 11
6 History 13
7 Competitors 14
8
ConvaTec Medical Equipment Market Share Analysis by Category 15
8.1
ConvaTec, Wound Care Management, Global, Market Share (2007) 15
8.2
ConvaTec, Wound Care Management, APAC, Market Share (2007) 17
8.3
ConvaTec, Wound Care Management, Europe, Market Share (2007) 19
8.4
ConvaTec, Wound Care Management, MEA, Market Share (2007) 23
8.5 ConvaTec,
Wound Care Management, North America, Market Share (2007) 25
8.6 ConvaTec,
Wound Care Management, SCA, Market Share (2007) 27
9 Key Employees 29
10 Company Statement 30
11 Locations And Subsidiaries 31
11.1 Head
Office 31
11.2 Other Locations & Subsidiaries 31
12 Financial Deals
Landscape 32
12.1 Private Equity 32
12.1.1 Nordic Capital Fund And
Avista Capital Partners To Acquire ConvaTec Business From Bristol-Myers Squibb
32
13 Recent Developments 35
13.1 Strategy and Business Planning
35
13.1.1 Nov 12, 2007: Alltracel Signs Development Agreement With
ConvaTec 35
13.2 Product Announcements 35
13.2.1 May 14, 2008
ConvaTec Introduces VERSIVA XC Gelling Foam Dressings To US 35
13.2.2 May
02, 2008 ConvaTec Upgrades Flexi-Seal Fecal Management System To Increase
Ease Of Use 36
13.2.3 Jan 22, 2008: Vivolution Acquires Patent From BMS
36
14 Appendix 37
14.1 Global Markets Direct Research Methodology
37
14.2 Coverage 38
14.3 Secondary Research 38
14.4 Primary
Research 39
14.5 Models 39
14.6 Forecasts 40
14.7 Expert Panels
40
14.8 Market Revenue Chapters 40
14.8.1 Abbreviations 40
14.8.2
Currency Conversions 41
14.9 About Global Markets Direct 42
14.10
Contact Us 42
14.11 Disclaimer 42